The genotoxic and cytotoxic effects of ribavirin in rat bone marrow
Authors:
- K NarayanaKNK Narayana
- Urban J.A D’souzaUDUrban J.A D’souza
- K.P Seetharama RaoKRK.P Seetharama Rao
- 1 November 2002
- journal article
- Published by Elsevier in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
- Vol. 521 (1-2) , 179-185
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Combination of interferon and ribavirin in chronic hepatitis C: Re-treatment of nonresponders to interferonHepatology, 2001
- An update on respiratory syncytial virus antiviral agentsExpert Opinion on Investigational Drugs, 2001
- Combination therapy with ribavirin and alpha interferon for the treatment of chronic hepatitis C refractory to interferonAlimentary Pharmacology & Therapeutics, 2001
- Mode of action of ribavirin: Effect of nucleotide pool alterations on influenza virus ribonucleoprotein synthesisAntiviral Research, 1985
- Hematological and bone marrow effects of ribavirin in rhesus monkeysToxicology and Applied Pharmacology, 1984
- Effects of ribavirin on red blood cellsToxicology and Applied Pharmacology, 1984
- Morphological Alterations in Blood and Bone Marrow of Ribavirin-Treated MonkeysActa Haematologica, 1984
- The broad spectrum antiviral agent ribavirin inhibits capping of mRNABiochemical and Biophysical Research Communications, 1979
- Failure of 1-β- d -Ribofuranosyl-1,2,4-Triazole-3-Carboxamide (Virazole, ICN 1229) to Stimulate InterferonAntimicrobial Agents and Chemotherapy, 1973
- Broad-Spectrum Antiviral Activity of Virazole: 1-β-D-Ribofuranosyl-1,2,4-triazole-3-carboxamideScience, 1972